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Iron Overload Accelerates 
the Progression of Diabetic 
Retinopathy in Association with 
Increased Retinal Renin Expression
Kapil Chaudhary1, Wanwisa Promsote2, Sudha Ananth3, Rajalakshmi Veeranan-Karmegam3, 
Amany Tawfik4, Pachiappan Arjunan4, Pamela Martin3, Sylvia B. Smith5, Muthusamy 
Thangaraju  3, Oleg Kisselev7, Vadivel Ganapathy6 & Jaya P. Gnana-Prakasam7
Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults. Increased iron 
accumulation is associated with several degenerative diseases. However, there are no reports on the 
status of retinal iron or its implications in the pathogenesis of DR. In the present study, we found that 
retinas of type-1 and type-2 mouse models of diabetes have increased iron accumulation compared 
to non-diabetic retinas. We found similar iron accumulation in postmortem retinal samples from 
human diabetic patients. Further, we induced diabetes in HFE knockout (KO) mice model of genetic 
iron overload to understand the role of iron in the pathogenesis of DR. We found increased neuronal 
cell death, vascular alterations and loss of retinal barrier integrity in diabetic HFE KO mice compared 
to diabetic wildtype mice. Diabetic HFE KO mouse retinas also exhibited increased expression of 
inflammation and oxidative stress markers. Severity in the pathogenesis of DR in HFE KO mice was 
accompanied by increase in retinal renin expression mediated by G-protein-coupled succinate receptor 
GPR91. In light of previous reports implicating retinal renin-angiotensin system in DR pathogenesis, 
our results reveal a novel relationship between diabetes, iron and renin-angiotensin system, thereby 
unraveling new therapeutic targets for the treatment of DR.
Diabetic retinopathy (DR) is a chronic progressive complication associated with prolonged hyperglycemia in 
diabetes mellitus. DR is the most common microvascular complication in diabetic patients that can progress to 
the loss of vision1. DR is characterized by inflammation, neurodegeneration and microvascular alterations in the 
retina2–5. The most common cause of vision loss depends on the type of diabetes, with type 1 diabetes presenting 
as proliferative retinopathy causing severe hemorrhage in the vitreous6, and with type 2 diabetes manifesting 
as macular edema caused by breakdown of the blood-retinal barrier7. Oxidative stress is considered to play an 
important role in the pathogenesis of DR8.
In the retina, there are many iron-containing proteins that are involved in the phototransduction cascade. 
Although an essential micronutrient for the function of many proteins, iron is a potentially harmful pro-oxidant 
when present in large quantities. Excess iron can undergo Fenton reaction, catalyzing the conversion of H2O2 
to hydroxyl radical, which is considered the most reactive oxygen species. Hydroxyl radicals cause lipid peroxi-
dation, DNA strand breaks, and degradation of cellular components leading to tissue damage9. Hence stringent 
mechanisms maintain iron levels by regulating proteins involved in iron homeostasis. Dysregulation of local iron 
homeostasis has been shown to play a role in the etiology of several neurodegenerative disorders like Parkinson’s, 
Alzheimer’s and amyotrophic lateral sclerosis10–13. Similarly, abnormal iron deposits have been associated with 
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ocular diseases such as age-related macular degeneration, cataracts and glaucoma14–16. In addition, there are clin-
ical reports on positive link between iron levels and proliferative retinopathies17–22, however, implications of the 
retinal iron imbalance in the pathogenesis of DR has not been elucidated.
Renin-angiotensin system (RAS) plays an important role in the control of blood pressure and electrolyte 
homeostasis. The enzyme Pro/renin cleaves its substrate, angiotensinogen, to form angiotensin I. Angiotensin 
converting enzyme (ACE) converts angiotensin I to angiotensin II, a potent vasoconstrictor and a stimulant of 
aldosterone release. Angiotensin II synthesis in numerous tissues and organs has demonstrated the presence of 
tissue-based RAS that are independent of circulating RAS23. Retina contains all the elements of RAS and intraoc-
ular Angiotensin II formation has been shown to be independent of the circulating RAS24. The tissue RAS acts 
in a paracrine/autocrine manner to regulate organ function and is involved in the pathologic events leading to 
end-organ damage. The retinal RAS has also been implicated in DR pathogenesis25. The Diabetic Retinopathy 
Candesartan Trials (DIRECT) reported that angiotensin receptor blocker (ARB) candesartan reduced retinopa-
thy development in normotensive normoalbuminuric diabetic patients without DR but not in patients with mild 
to moderate DR26,27. The Renin-Angiotensin System Study (RASS) found significant delay in the progression of 
retinopathy in diabetic patients treated with the angiotensin-converting-enzyme inhibitor (ACEI)28.
GPR91 is a G-protein–coupled receptor for succinate29. Imbalance in the local tissue energy demand and 
supply leads to the citric acid cycle intermediate succinate, which is normally present within the mitochondria, 
to be released into the extracellular medium. The extracellular succinate serves as an agonist for GPR9130. In the 
kidney, succinate-induced activation of GPR91 has been shown to regulate the expression of renin-angiotensin 
system31,32. GPR91 is expressed in retinal ganglion cells and retinal pigment epithelium33,34. We have reported 
previously that retinal iron overload induces GPR91 expression in the retinas of HFE and hemojuvelin knockout 
mice models of hemochromatosis, a genetic disorder of iron overload, and subsequently stimulates the produc-
tion of downstream vascular endothelial growth factor (VEGF)34,35. HFE is an important iron regulatory protein 
that senses cellular iron status and regulates iron uptake by competitively inhibiting transferrin receptor. We have 
previously reported that HFE is expressed predominantly in the basolateral membrane of the retinal pigment 
epithelium, and HFE knockout (KO) mice accumulate iron in the retina with significant retinal degeneration 
by 18 months of age36. In the present study, we induced diabetes in HFE knockout (KO) mice to understand the 
mechanistic role of iron, GPR91 and renin angiotensin system in the pathogenesis of DR.
Results
Increased iron accumulation in diabetic retina. Iron levels in serum and eye tissues were measured in 
type 1 and type 2 diabetic mouse models by quantifying ferritin, an iron-storage protein, which is upregulated 
during intracellular iron accumulation. Type 1 diabetes was induced in C57BL/6 mice by intraperitoneal injec-
tion of streptozotocin (STZ). BKS.Cg Leprdb/J (db/db) mice model was used for type 2 diabetes. Ferritin levels 
were found to be significantly upregulated in the serum and eye tissues of type 1 and 2 diabetic mice compared 
to non-diabetic control mice using ELISA (Fig. 1A). Western blot (Fig. 1B) and immunofluorescence (Fig. 1C) 
showed upregulation of heavy chain (H-) and light chain (L-) ferritin levels in the retina of type 1 (STZ) and type 
2 (db/db) diabetic mice. Labile iron staining using FeRhoNox-1 fluorescent imaging probe confirmed increased 
Fe2+ iron accumulation in the diabetic mice (Fig. 1D) and the diabetic human (Fig. 1E) retinal sections demon-
strating that retina accumulates iron during diabetes.
Increased outer and inner retinal barrier dysfunction in diabetic mice with iron overload. To 
understand if iron accumulation alters the pathogenesis of diabetic retinopathy, we induced diabetes in HFE KO 
mice, a genetic model of iron overload, using STZ. We reported previously that HFE KO mice have increased 
retinal iron accumulation with age-dependent retinal degeneration36,37. In the present study, we confirmed that 
retinal iron accumulation was 2-fold higher in HFE KO diabetic mice compared to HFE WT diabetic mice as 
indicated by ferritin upregulation in the eye tissues of diabetic HFE KO mice using western blot and ELISA 
(Fig. 2A,B).
Maintaining the two components of blood retinal barrier (BRB), outer RPE cell and inner endothelial cell 
integrity, is quintessential for retinal health. Alterations of the BRB play a crucial role in the development of DR38. 
To evaluate if iron overload during diabetes affects barrier integrity, we prepared RPE flatmounts from control 
and diabetic HFE WT and KO mouse eyes and stained for the tight-junction protein zona occludens-1 (ZO-1) 
to assess outer retinal barrier integrity (Fig. 3A). There was no significant difference in ZO-1 staining between 
non-diabetic HFE WT and KO control mice (Fig. 3A, top panel). ZO-1 labeled flat-mount preparations from 
12-week post diabetic HFE WT mice retained the characteristic RPE phenotype showing a monolayer of uni-
formly stained cobblestone-shaped RPE cells (Fig. 3A, bottom left panel). On the contrary, RPE flat mounts from 
12-week post diabetic HFE KO mice had hypertrophied RPE cells of abnormal shape along with a disruption 
in the continuity of ZO-1 staining in some areas (Fig. 3A, bottom right panel). For quantitative confirmation 
of ZO-1 labeling observed in immunostained flat-mounts, western blot analysis was performed with proteins 
extracted from the RPE of diabetic and non-diabetic HFE WT and KO mice. ZO-1 protein expression was signif-
icantly reduced in diabetic HFE KO mice compared to diabetic HFE WT mice with no significant difference in 
ZO-1 protein levels between non-diabetic HFE WT and KO control (Fig. 3B). To determine if disruption of the 
tight junction in turn affects barrier integrity, primary RPE cells were prepared from HFE WT and KO mouse 
eyes and cultured for 6 weeks in the presence of normal glucose (5.5 mM) or high glucose (25 mM) on permeable 
transwell for the formation of confluent monolayer. The apical-to-basolateral movement of 40- kD FITC-Dextran 
dye was measured as an indicator of transepithelial permeability (Fig. 3C). The increase in the accumulation of 
dye in the basolateral compartment of HFE KO RPE cells grown in high glucose condition indicates that these 
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cells were significantly more permeable to FITC- Dextran than HFE WT RPE cells grown in high glucose condi-
tion. These findings for the first time implicates retinal iron overload directly to disruption of BRB.
Retinas of non-diabetic control and diabetic HFE WT and KO mice were evaluated using Micron III in-vivo 
retinal imaging microscope. Fundoscopic imaging of non-diabetic HFE WT and KO mice demonstrated no signs 
of abnormality, and the retinas of these animals appeared to be healthy. Simultaneous fluorescein angiography 
of these retinas showed normal retinal vasculature (Fig. 3D, top panel). In contrast, fundoscopic imaging and 
fluorescein angiography of diabetic HFE WT and KO mice showed increase in pigmentary and vascular abnor-
malities. At 8-weeks post diabetes, WT diabetic eyes showed no signs of retinal pathology. However, vascular 
anomalies were detected frequently early on in HFE KO diabetic eyes. By 12- weeks (Fig. 3D, middle panel) and 
Figure 1. Iron accumulation in diabetic retina. (A) Quantification of ferritin levels in the (a) serum and (b) 
eye tissues of 12-week type 1 (STZ) and type 2 (db/db) diabetic mice by ELISA. (B) Heavy chain H-ferritin and 
light chain L-ferritin levels in the retinas of type 1 (STZ) and type 2 (db/db) diabetic mice models by western 
blot. Blots cropped from different parts of the same gel or from different gels are separated by white space. 
(C) Representative images of retinal sections from control vs type 1 (STZ) and type 2 (db/db) diabetic mice 
immunostained for (a) heavy chain H-ferritin and (b) light chain L-ferritin. (D) Labile iron (Fe2+) in retinal 
tissues of control vs type 1 (STZ) and type 2 (db/db) 12-week diabetic mice were detected using FeRhoNox-1 
fluorescent imaging probe. (E) Representative images of retinal sections from normal and diabetic human 
patients (Diabetic retinopathy, DR) stained for labile iron (Fe2+) using FeRhoNox-1 fluorescent imaging 
probe. GCL-Ganglion Cell Layer, INL-Inner Nuclear Layer, ONL-Outer Nuclear Layer, RPE-Retinal Pigment 
Epithelium. *p < 0.05; **p < 0.001; ***p < 0.0001.
Figure 2. Ferritin expression is upregulated in the retina of diabetic HFE KO mice model of iron overload. (A) 
Western blot for Heavy chain (H-) and Light chain (L-) Ferritin in the retina of non-diabetic control and 16-
week diabetic HFE WT and KO mice. β-actin was used as a loading control. Blots cropped from different parts 
of the same gel or from different gels are separated by white space. (B) ELISA for ferritin in the retina of non-
diabetic and diabetic HFE WT and KO mice. *p < 0.05; **p < 0.001.
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16-weeks post diabetes (Fig. 3D, bottom panel), the incidence of tortuous vessels, arteriovenous crossings and 
retinal vein occlusion with associated pigmentary abnormalities were much higher in diabetic HFE KO mice in 
comparison to diabetic HFE WT mice.
Increased neuronal cell loss in retina of diabetic mice with iron overload. To determine if retinal 
iron accumulation during diabetes causes apoptosis of retinal cells, we performed TUNEL assay in eye sections 
from the 12-week diabetic HFE WT and KO mice. The cells with significantly higher apoptosis were found in the 
ganglion cell layer (GCL) of diabetic HFE KO mice in comparison to diabetic HFE WT mice. After GCL, there 
was considerable increase in apoptotic cells in the inner nuclear layer (INL), outer nuclear layer and to a lesser 
extent in the RPE of diabetic HFE KO mice compared to diabetic HFE WT mice (Fig. 4A). We did not find any 
apoptotic cells in the non-diabetic HFE WT and KO control (data not shown). Hematoxylin and eosin stained 
retinal sections from non-diabetic WT and KO mice showed normal morphology (Fig. 4B, top panel). While 
16-week post diabetic HFE WT mice had mild cell loss in the GCL and INL (Fig. 4B, medium panel), sections 
from diabetic HFE KO mice showed significant loss of cells in GCL and INL, with focal points where photore-
ceptor cells migrated towards RPE layer (Fig. 4B, bottom panel). Since we found maximum apoptosis and cell loss 
in GCL, we quantified the average number of cells present in GCL per 100 μm in central and peripheral retina. 
GCL of diabetic HFE KO mice had 50% reduction in cell number compared to diabetic HFE WT mice both in the 
central and peripheral retina with no difference in cell number between non-diabetic HFE WT and KO control 
retina (Fig. 4C).
Increased oxidative stress and inflammation in diabetic mice with iron overload. Oxidative 
stress and inflammation are postulated to promote diabetic retinopathy39,40. Animal studies have demonstrated 
that oxidative stress contributes to the development of DR as well as to the resistance of retinopathy to reverse 
after glycemic control is normalized41. Here we determined whether the expression of oxidative stress marker 
increased with retinal iron accumulation during diabetes. 4-hydroxynonenal (HNE), a lipid peroxidation prod-
uct, is upregulated during oxidative stress42. Immunostaining of retinal cryosections for 4-HNE revealed mild 
fluorescence signal in retinal sections from non-diabetic HFE KO control in comparison to non-diabetic HFE 
WT control that did not have any positive fluorescence staining. Also, we found robust increase in the fluorescent 
Figure 3. Altered outer and inner retinal barrier function in diabetic HFE KO mice. (A) Tight junction protein 
Zonula occludin-1 (ZO-1) immunofluorescence in retinal pigment epithelium (RPE) flat mounts prepared 
from non-diabetic control and 16-week post-diabetic HFE WT and KO mice. (B) Western blot analysis of ZO-1 
expression in protein extracted from the RPE of non-diabetic and diabetic HFE WT and KO mice. β-actin 
was used as a loading control. Blots cropped from different parts of the same gel or from different gels are 
separated by white space. (C) FITC-Dextran (40-kD) trans epithelial permeability assay performed on confluent 
monolayers of primary RPE cells established from HFE WT and HFE KO mouse eyes grown in normal glucose 
(5.5 mM) or high glucose (25 mM). Data are presented as mean ± S.E. *p < 0.01. (D) Fluorescein angiography 
and fundoscopic imaging of non-diabetic control vs diabetic HFE WT and KO mice.
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intensity in diabetic HFE KO retinal sections compared to diabetic HFE WT sections (Fig. 5A). However, this 
effect was not surprising as it is known that iron overload promotes Fenton’s reaction, thereby increasing oxidative 
stress9. Labile iron was recently found to activate NLRP3 (NLR Family Pyrin Domain Containing 3) inflammas-
ome signaling pathway and its downstream targets interleukin IL-1ß and active caspase-143,44. To confirm these 
observations, we evaluated the expression of NLRP3 and IL-1ß by RT-PCR. We found increase in the expression 
Figure 4. Accelerated neuronal cell loss and morphological changes in retina of diabetic HFE KO mice. (A) 
TUNEL assay in the eye sections of diabetic HFE WT and KO mice. Green signals indicate apoptotic cells. (B) 
Hematoxylin and eosin stained retinal sections from non-diabetic HFE WT and KO mice (top panel) compared 
to diabetic HFE WT (middle panel) and diabetic HFE KO mice (bottom panel) (C) Quantification of number 
of cells in ganglion cell layer in the central and peripheral regions of retinal sections from non-diabetic and 
diabetic HFE WT and KO mice. *p < 0.01.
Figure 5. Increased oxidative stress and NLRP3 inflammasome activation in retina of diabetic HFE KO mouse 
model of iron overload. (A) 4-Hydroxynonenal staining in non-diabetic control and diabetic HFE WT and KO 
mouse retina. (B) Expression levels of NLRP3 and IL-1ß mRNA in non-diabetic control and diabetic HFE WT 
and KO mouse retina by RT-PCR (C) Active caspase-1 levels detected using the FAM-FLICA Assay Kit (green). 
Data are presented as mean ± S.E. *p < 0.01, **p < 0.001.
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levels of NLRP3 and IL-1ß in the retinas of diabetic HFE WT mice compared to non-diabetic HFE WT control 
mice, and the upregulation of NLRP3 and IL-1ß were more significant in diabetic HFE KO mice than diabetic 
HFE WT mice (Fig. 5B). Activated caspase-1, another downstream target of NLRP3 was also enhanced in diabetic 
HFE KO mice than in diabetic HFE WT mice with no detectable staining in the non-diabetic HFE WT and KO 
control (Fig. 5C) indicating that retinal iron overload during DR accelerates NLRP3 inflammasome signaling 
pathway. This is a significant finding considering a recent report showing NLRP3 inflammasome activation to 
be associated with the pathogenesis of proliferative diabetic retinopathy (PDR)45. Along with VEGF, the lev-
els of caspase-1 and IL-18 were found to be predominantly increased in the vitreous samples of PDR patients. 
Interestingly, significantly higher levels of NLRP3 were present in the vitreous of PDR patients with tractional 
retinal detachment than in PDR patients with fully attached retina45.
Retinal renin expression is induced through succinate receptor GPR91 in diabetic mice with 
iron overload. Succinate, an intermediate of glucose metabolism, has been shown to induce the expression 
of renal renin by signaling through its receptor GPR9131,32. We have reported previously that retinal iron overload 
enhances GPR91 expression in HFE and hemojuvelin knockout mouse models of hemochromatosis, a genetic 
disorder of iron overload34,35. In this study, we determined if retinal iron overload during DR activates GPR91 
and thereby induces retinal renin expression. We found significant increase in retinal renin expression in the 
diabetic HFE KO mice compared to the diabetic HFE WT mice by RT-PCR and western blot (Figs. 6A and 6B). 
To determine if iron overload induces renin expression through GPR91 signaling, renin mRNA levels in ARPE-
19 cells with normal expression of GPR91 was compared to GPR91 knockdown ARPE-19 cells, in the presence 
or absence of ferric ammonium citrate (FAC) and succinate. As reported in our previous publication34, among 
the four GPR91-specific shRNAs tested, two shRNAs (shRNA1 and shRNA2) showed significant knockdown of 
GPR91 expression34. We confirmed the GPR91 knockdown in cells treated with shRNA1 and 2 by Real time-PCR 
(Fig. 6C) before using the cells for the present study. Renin mRNA expression was upregulated in control ARPE-
19 cells treated with FAC and succinate, while this upregulation in renin expression was significantly reduced in 
GPR91 knockdown ARPE-19 cells treated with FAC and succinate (Fig. 6D). These results indicate that renin 
expression in iron-overloaded RPE cells is induced by succinate-GPR91 signaling (Fig. 7).
Figure 6. Iron overload during diabetic retinopathy upregulates retinal renin expression in a GPR91 dependent 
mechanism. (A) Pro/renin mRNA quantified in retina of non-diabetic and diabetic HFE WT and HFE KO 
mice by RT PCR (B) Renin protein levels quantified in retina of non-diabetic and diabetic HFE WT and HFE 
KO mice by western blot. Blots cropped from different parts of the same gel or from different gels are separated 
by white space. (C) Lentivirus-mediated knockdown of GPR91 expression in ARPE-19 cells treated with two 
different GPR91-specific shRNAs34. GPR91 knockdown was quantified by RT-PCR with 18S RNA as an internal 
control. Control ARPE-19 cells (vector only) and GPR91 shRNA-expressing ARPE-19 cells were treated with 
100 μg/mL FAC for 72 hours, and during the last 16 hours of this 72-hour FAC treatment, cells were incubated 
with or without 2 mM succinate. (D) Renin mRNA levels were analyzed using RT-PCR in RNA from control 
ARPE-19 cells (vector only) and GPR91 shRNA-expressing ARPE-19 cells with or without the treatment of FAC 
and succinate. 18S RNA was used as an internal control. Data presented as mean ± SE of three experiments. 
*p < 0.05; **p < 0.001; ***p < 0.0001.
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Discussion
There is a lack of understanding on the link between tissue iron and DR progression. The present study demon-
strates that retina accumulates iron during diabetes. We have shown here for the first time that systemic iron 
overload during diabetes exacerbates the progression of DR in mice. We have a novel finding that during DR, 
retinal iron overload affects blood retinal barrier integrity and accelerates retinal cell loss by enhancing oxida-
tive stress and NLRP3 inflammasome signaling. Another important outcome of the present study is that iron 
overload induces retinal renin expression through succinate receptor GPR91 signaling. The significance of this 
discovery is evident from many clinical reports demonstrating that renin-angiotensin system inhibitors delay DR 
progression46.
Increased oxidative stress and inflammation is considered a causal link between hyperglycemia and other 
metabolic anomalies involved in the pathogenesis of diabetic complications. Many clinical reports indicate that 
type 2 diabetic patients have elevated iron deposits and total body iron stores than non-diabetic control pop-
ulation47–51. Emerging studies suggest that excess body iron52–54 or high intake of dietary iron55,56 is related to 
the pathogenesis of diabetic complications. Strong evidences link iron to diabetic nephropathy with increased 
iron in diabetic animal kidneys57,58 and human urine59. Most importantly, low-iron diet or iron chelators have 
been shown to delay diabetic nephropathy progression60,61. The present study is the first report on the role of 
iron in the pathogenesis of diabetic retinopathy. During DR, the retinal microenvironment may accumulate iron 
by various mechanisms. Hyperglycemia has been reported to cause break down of heme containing molecules 
releasing free iron62. Intraretinal and intravitreal hemorrhages associated with DR also results in additional iron 
overload. Importantly, studies from our lab and others strongly suggest that inflammation can alter the expression 
of iron-regulatory gene hepcidin leading to iron accumulation42,63. On the contrary, diabetes is a common com-
plication in patients with mutation in iron-regulatory proteins like hemochromatosis, and iron accumulation will 
exponentially increase during the progression of DR in these patients19–21. Thus our present study demonstrating 
iron accumulation in diabetic retina and the acceleration of DR progression with excess iron has high clinical 
significance.
DR is considered a microcirculatory disease of the retina triggered by hyperglycemia. However, studies from 
the past two decades indicate retinal neurodegeneration as an early event in the pathogenesis of DR occurring 
prior to the microcirculatory abnormalities in DR64. Therefore, the study of mechanisms that lead to neurode-
generation will help in identifying new therapeutic targets for the early stages of DR. Overexpression of reti-
nal renin-angiotensin system has been shown to play a vital role in the neurodegeneration during DR65–67. The 
effects of renin-angiotensin system on retinal blood vessels are well established, causing vasoconstriction of 
retinal arterioles and capillaries68. In addition to vasoconstriction, RAS is known to modulate other functions 
such as endothelial cell migration, proliferation and angiogenic growth factor expression69,70. Diabetes has been 
shown to significantly induce plasma and renal prorenin levels by more than 20-fold in GPR91+/+ mice but this 
increase was greatly inhibited in diabetic GPR91−/− mice31. It has been shown recently that during hyperglyce-
mia increase in succinate levels acts through GPR91 to trigger VEGF release in retinal ganglion cells by signaling 
extracellular signal-regulated kinase 1/2 (ERK1/2), p38 mitogen-activated protein kinase (p38 MAPK) and c-Jun 
N-terminal kinase (JNK)33,71. We have reported previously that retinal iron overload upregulates GPR91 expres-
sion and subsequently enhances the levels of pro-angiogenic factors like VEGF and angiopoietin in genetic mouse 
models of iron overload34,35. Here, we have shown that iron accumulation during diabetes upregulates retinal 
renin expression in a GPR91-dependent manner. The plasma and intrarenal renin is found to be activated early in 
Figure 7. Illustration of the pathways linking iron and renin angiotensin system in diabetic retina. A schematic 
of the signaling pathways involved in the induction of retinal renin angiotensin system (RAS) during diabetes 
mediated by iron overload, GPR91 and succinate.
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diabetes; yet the exact mechanism is not known. This is the first study to demonstrate that iron overload regulates 
local renin expression.
Retina is constantly exposed to oxidative stress caused by photo-oxidation, and regulation of iron homeosta-
sis within this tissue is important to prevent exacerbation of this oxidative stress by iron overload. The harmful 
effects of iron overload in causing inflammation and oxidative stress has been recognized for many decades. 
However, the results from this study identify a novel interaction between iron, GPR91 and RAS that plays an 
important role in neurodegeneration and vascular abnormalities associated with diabetes. Future experiments 
will be directed at using GPR91 knockout mouse model to understand the downstream pathways that are altered 
due to retinal renin overexpression during iron overload associated with DR. Without knowledge of retinal iron 
levels, intake of iron-rich diet or iron supplements by patients with diabetes may lead to a precarious situation. 
Hence it is critical to study the mechanisms by which iron contributes to retinal degeneration during DR. Further 
studies are warranted to confirm the effectiveness of iron chelators, GPR91 antagonists and renin-angiotensin 
inhibitors to prevent the exacerbation of DR progression caused by retinal iron overload. This knowledge will 
offer new avenues and targets for the treatment of not only diabetic retinopathy but also other vascular and neu-
ronal disorders associated with iron overload.
Materials and Methods
Materials. Reagents were obtained from the following sources: reagent for RNA preparation, TRIzol 
(Invitrogen-Gibco Corp., Grand Island, NY), DMEM/F12 culture medium (Invitrogen-Gibco Corp., Grand 
Island, NY), RT-PCR kit (Applied Biosystems Inc., Foster City, CA), Taq polymerase kit (TaKaRa, Tokyo, Japan) 
and SyBr Green for Realtime PCR from Applied Biosystems Inc., (Foster City, CA). Rabbit polyclonal anti-4-hy-
droxynonenal (HNE) was from Alpha Diagnostic International (San Antonio, TX) and rabbit polyclonal anti 
zona occludens-1 (anti ZO-1) was from Abcam (Cambridge, MA). Rabbit anti-H-ferritin and rabbit anti-L-fer-
ritin antibodies were a generous gift from Dr. Paolo Arosio, University of Brescia, Brescia, Italy. Goat anti-rabbit 
IgG coupled to Alexa Fluor 568 and goat anti-rabbit Alexa Fluor 488 were from Molecular Probes (Carlsbad, CA). 
FeRhoNox-1 fluorescent imaging probe was obtained from Goryo Chemical (Sapparo, Japan). Mouse ferritin 
ELISA kit was obtained from Kamiya Biomedical Company (Seattle, WA, U.S.A.).
Animals. Breeding pairs of HFE+/− mice were obtained from the Jackson Laboratory (Bar Harbor, ME). 
Normal male C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and used for induc-
tion of type 1 diabetes using intraperitoneal injection of streptozotocin per our previously published method72. 
For type 2 diabetes mice model, male BKS.Cg Leprdb/J (db/db) mice aged 12 weeks and age-matched wild-type 
(WT) C57BLKS/J mice were also obtained from Jackson Laboratory. Histologic processing of mouse eyes was 
performed following our previously published protocol34. All procedures involving mice were approved by 
the Augusta University and Saint Louis University Institutional Committee on Animal Use for Research and 
Education, and were performed in accordance with the Association for Research in Vision and Ophthalmology 
Statement for the Use of Animals in Ophthalmic and Vision Research.
Postmortem human retina specimens. OCT frozen sections from normal and diabetic retinopathy 
patients were commercially obtained from National Development and Research Institute (NDRI) with per-
mission of exemption from Augusta University Institutional Review Board (IRB). The Augusta University IRB 
Committee approved all procedures involved in tissue procurement from NDRI. The methods were carried out 
in accordance with the approved guidelines and regulations.
Preparation of retinal tissues for immunostaining and RNA isolation. Mouse eyes were embedded 
in OCT compound and frozen at −80 °C. Sections (8-μm thick) were used for immunostaining. For preparation 
of RNA from posterior segments, corneas and lenses were removed using a stereomicroscope, and the posterior 
cup with retina was collected for RNA preparation.
Real-time PCR. The following primers were used for quantification of mRNA by Real-time PCR: mouse 
NLRP3 forward primer 5′-TGCCTGTTCTTCCAGACTGGTGA-3′ and reverse primer 5′-CACAGCACCCT 
CATGCCCGG-3′; mouse IL-1β GCCCATCCTCTGTGACTCATAGGCCAC AGGTATTTTGTCG; mouse 
Pro/renin forward primer 5′-TCTGGGCACTCTTGTTGCTC-3′ and reverse primer 5′-GGGGGAGGT 
AAGATTGGTCAA-3′. Primers for human GPR91 were 5′-GGGGAGAAGAGAAGAGAAGAG-3′ (forward) 
and 5′-CACGGCATTGGACATGTA-3′ (reverse) and human renin were 5′-CCACCTCCTCCGTGATCCT-3′ 
(forward) and 5′-CGCCATAGTACTGGGTGTCCAT-3′ (reverse). Each PCR experiment was repeated at least 
three times with similar results. 18S mRNA was used as the internal control for PCR reaction. Real-time amplifi-
cations using detection chemistry (SYBR Green; Applied Biosystems), were run in triplicates on 96-well reaction 
plates using Step One Plus Real time PCR System.
Immunofluorescence analysis. Retinal sections, fixed in 4% paraformaldehyde and blocked with 1× 
power block, were incubated overnight at 4 °C with one of the following primary antibodies: polyclonal rabbit 
anti-H-ferritin (1: 2,000), rabbit anti-L-ferritin (1: 2,000) or rabbit anti-HNE (1:500 dilution). Negative controls 
involved omission of the primary antibodies. Sections were rinsed and incubated for 1 hour with goat anti-rabbit 
IgG coupled to Alexa Fluor 568. Active caspase-1levels detected using the FAM-FLICA Assay Kit. Coverslips 
were mounted after staining with Hoechst nuclear stain, and sections were examined by laser-scanning confocal 
microscopy (Carl Zeiss, Oberkochen, Germany). Immunohistochemistry studies were repeated twice, and the 
results from these two experiments were similar.
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Histological detection of labile Fe(II). Labile iron (Fe2+) in retinal sections were detected using 
FeRhoNox-1 fluorescent imaging probe as mentioned in publications73,74. RhoNox-1 was dissolved in dimethyl 
sulfoxide to produce a 1 mM solution, which was further diluted to a final concentration of 5 μM. This diluted 
solution was prepared fresh just before use. Frozen retinal sections of 8 μm thickness were air dried for 3 min, 
fixed in 4% paraformaldehyde for 1 min, and washed in deionized water briefly. Then, 200 μl of 5 μM RhoNox-1 
was placed on the retinal sections and incubated for 30 min at 37 °C in a dark chamber. The sections were then 
counterstained with Hoechst nuclear stain and observed using laser-scanning confocal microscopy.
Western blot analysis. Protein was extracted from retinal tissues and concentration was determined using 
the bicinchoninic acid (BCA) assay (Thermo Fisher Scientific, Rockford, IL). 20 μg of protein were subjected to 
SDS–PAGE, transferred to nitrocellulose membranes, and then incubated with primary antibodies overnight at 
4 °C. Secondary detection was done using horseradish peroxidase– conjugated secondary antibodies (Promega, 
Madison, WI). After washing, the proteins were visualized using enhanced chemiluminescence (ECL) western 
blot detection system (Thermo Fisher Scientific). β- actin served as the loading control. Western blot analysis was 
repeated twice with comparable results.
Enzyme-linked immunosorbent assay. A mouse ferritin ELISA kit (mentioned in Materials) was used 
for quantification of ferritin levels in mouse serum and retinas as published previously75. A calibration curve was 
used as instructed in the kit to determine ferritin levels. ELISA plates were read spectrophotometrically at 450 nm 
using a SpectraMAX 190 plate reader (Molecular Devices, Sunnyvale, CA).
Measurement of reactive oxygen species. Excessive iron accumulation in cells generates hydroxyl radi-
cals via the Fenton reaction, which then promote lipid peroxidation. 4-Hydroxynonenal is one of the by-products 
of lipid peroxidation and is widely used as a marker of oxidative stress. Retinal sections were stained with 
anti-HNE antibody as per our published method76.
In situ detection of DNA fragmentation by TUNEL assay. TUNEL assay was performed using the 
ApopTAG fluorescein in situ apoptosis detection kit. After staining, the tissue sections were viewed by epiflu-
orescence using standard fluorescence excitation and emission filters. Each section was scanned systematically 
from the temporal to the nasal ora serrata for fluorescent cells indicative of apoptosis. To distinguish between 
structures that autofluoresced versus those that were TUNEL-positive, all slides were examined first with the 
rhodamine filter and then with the FITC filter. Autofluorescent structures were visible under both filters, whereas 
TUNEL-positive cells were detectable only with the FITC filter.
RPE flat mount. RPE whole mount was prepared as described by Longbottom et al.77. In brief, RPE/eyecups 
were dissected from unfixed eyes and then fixed in ice cold methanol for at least overnight, and processed for 
immunohistochemistry. The fixed RPE/eyecups were blocked with 0.1% BSA, 2% goat serum, and 0.1% Triton-X 
in PBS for 1 hour. Subsequently, the RPE/eyecups were incubated with a rabbit polyclonal antibody against ZO-1 
(1:100) diluted in the blocking solution overnight at 4 °C, and then with goat anti rabbit Alexa Fluor 488 second-
ary antibody for 1 hour at room temperature. RPE/eyecups were then cut partially at four places to allow the tissue 
to be flattened upon Superfrost microscope slides (Fisher Scientific, Pittsburgh, PA) and viewed by laser-scanning 
confocal microscopy.
Establishment of mouse primary RPE cell cultures. Age-matched WT and HFE KO mice were 
obtained from the same litter originating from the mating of heterozygous mice. Three-week-old mice were used 
to establish primary cultures of RPE as described previously42.
Treatment of RPE cells with ferric ammonium citrate. Primary RPE cells and human RPE cell lines 
ARPE-19 and HRPE were seeded in 24-well culture plates and cultured for 24 hours. Fresh culture medium was 
then added to cells with or without ferric ammonium citrate (FAC) (100 μg/mL), and the cells were cultured for 
an additional 72 hours. Cells were then used for RNA extraction. The concentration of FAC and the treatment 
time were selected based on published reports to cause iron overload in cells for optimal iron-induced gene 
expression changes36.
Transepithelial permeability assay. HFE WT and KO primary RPE cells were seeded on non-coated 
membranes with 0.4 μm pores (Transwell; Corning Costar), in Dulbecco’s modified Eagle’s medium: nutrient 
mixture F-12 (DMEM/F-12). After becoming completely confluent, FITC- dextran (40 kDa; Sigma-Aldrich) was 
then added to the upper chambers and samples from the lower and upper chambers were obtained at different 
time points. The concentration of FITC-dextran in these samples was quantified by microplate reader (ELx800; 
Bio-Tek). The diffusion rate was calculated as (amount of dextran lower chamber)/(amount of dextran upper 
chamber) and expressed as relative quantification. Each experiment was repeated four times.
Fundus and angiography analyses. To evaluate retinal integrity as well as vasculature and permeability 
in vivo, mice were anesthetized using a 20 µl intramuscular injection of rodent anesthesia cocktail (ketamine 
100 mg/mL, xylazine 30 mg/mL, acepromazine 10 mg/mL). Pupils were dilated using 1% tropicamide (Bausch and 
Lomb, Rochester, NY). The mouse was placed on the imaging platform of the Phoenix Micron III retinal imag-
ing microscope (Phoenix Research Laboratories, Pleasanton, CA), and Goniovisc 2.5% (hypromellose; Sigma 
Pharmaceuticals, LLC, Monticello, IA) was applied liberally to keep the eye moist during imaging. For angiogra-
phy analysis, mice were administered 10 to 20 μl fluorescein sodium (10% Lite) (Apollo Ophthalmics, Newport 
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Beach, CA) (while also receiving Goniovisc 2.5% [hypromellose; Sigma Pharmaceuticals, LLC]), and rapid acqui-
sition of fluorescent images ensued for approximately 5 minutes as mentioned in our previous publication78.
shRNA-induced silencing of GPR91 in ARPE-19 cells. Lentiviral-based shRNAs were used to knock 
down GPR91 in ARPE-19 cells as published previously34. We generated stable cell lines of ARPE-19 with GPR91 
knockdown using gene-specific shRNA constructs with the lentivirus plasmid vector pLKO.1-puromycin (Open 
Biosystems, Huntsville, AL). The following two constructs which had maximum knockdown34 were used: shRNA1 
(clone TRCN0000008976) and shRNA2 (clone TRCN0000008977). Stable cell lines were generated by infecting 
ARPE-19 cells independently with one of the two lentiviral-shRNA constructs and then selecting stable cell lines 
by puromycin (1 μg/mL) resistance. A stable cell line with a lentiviral vector only, without the shRNA, was used 
as the negative control. Knockdown of GPR91 expression was verified by RT-PCR. The sequences of shRNAs 
are as follows: CCGGGCCTCTCAACTTGGTCATCATCTCGAGATGATGACCAAGTTGAG AGGCTTTTT 
(shRNA1); CCGGCGGCTACATCTTCTCTCTGAACTCGAGTTCAGAGA GAAGATGTAGCCGTTTTT 
(shRNA2).
Data analysis. All experiments were repeated three to five times with independent cell or tissue prepara-
tions and samples run in duplicate. Data are presented as mean ± standard error of the mean (SEM). Statistical 
significance was determined with the Student t test, and one- way ANOVA with Tukey–Kramer’s post-hoc tests 
for comparisons between two groups or multiple groups, respectively. Differences were considered statistically 
significant at p < 0.05.
Data availability statement. The datasets generated and analyzed during the current study are available 
from the corresponding author on reasonable request.
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